Quipt Home Medical (NASDAQ: QIPT) delists common shares via Form 25

Rhea-AI Filing Summary

Quipt Home Medical Corp. submitted a Form 25 notification to remove its Common Shares from listing and registration on the Nasdaq Stock Market LLC. Nasdaq certified it has reasonable grounds for the filing and the Exchange and the issuer each attested compliance with the cited rules under 17 CFR 240.12d2-2 and 17 CFR 240.12d-2(c).

The form lists the issuer's principal office at 1019 Town Drive, Wilder, Kentucky 41076 and provides a telephone number. The notification is signed on behalf of Nasdaq by Tara Petta, AVP.

UNITED STATES

OMB APPROVAL

OMB Number:			3235-0080
Expires:	March 31, 2018
Estimated average burden
hours per response:			1.7

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION
UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-40413

Issuer:	Quipt Home Medical Corp.
Exchange:	Nasdaq Stock Market LLC

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

Address:	1019 Town Drive
	Wilder	KENTUCKY	41076
Telephone number:					647-268-0203

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Common Shares

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

17 CFR 240.12d2-2(a)(1)

17 CFR 240.12d2-2(a)(2)

17 CFR 240.12d2-2(a)(3)

17 CFR 240.12d2-2(a)(4)

Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. ¹

Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with its rules of the Exchange and the requirements of 17 CFR 240.12d-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements fo the Securities Exchange Act of 1934, Nasdaq Stock Market LLC certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

2026-03-16	By	Tara Petta		AVP
Date		Name		Title

¹ Form 25 and attached Notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What action does Quipt Home Medical (QIPT) disclose in this Form 25?

Answer: The filing notifies the removal of Quipt Home Medical's Common Shares from listing and registration on Nasdaq. The Exchange certified reasonable grounds for the Form 25 and the issuer and Exchange attested compliance with 17 CFR 240.12d2-2 and 17 CFR 240.12d-2(c).

Who certified and signed the Form 25 for the Nasdaq removal?

Answer: Nasdaq Stock Market LLC certified the notification and it was signed on its behalf by Tara Petta, identified as AVP. The signature represents Nasdaq's certification under the Securities Exchange Act procedures included in the submission.

What class of securities is being removed according to the filing?

Answer: The filing identifies the affected class as Common Shares. The Form 25 references the specific rules under 17 CFR 240.12d2-2 governing delisting and the issuer's voluntary withdrawal procedures under 17 CFR 240.12d-2(c).

Where is Quipt Home Medical's principal executive office listed in the Form 25?

Answer: The Form 25 lists the principal executive office at 1019 Town Drive, Wilder, Kentucky 41076 and provides a contact phone number of 647-268-0203. These contact details are included on the form's cover information.

Does the Form 25 state whether the issuer or Nasdaq complied with delisting rules?

Answer: Yes. The filing states the Exchange complied with its rules to strike the securities and that the issuer complied with the Exchange's rules and the requirements of 17 CFR 240.12d-2(c) governing voluntary withdrawal of listing and registration.